J H Chen1, W P Chen, S Chan, D C Yeh, M Y Su, C E McLaren. 1. Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California Irvine, Irvine, USA. jeonhc@uci.edu
Abstract
BACKGROUND: We measured breast density (BD) on MRI and correlated with endogenous hormonal levels. PATIENTS AND METHODS: Twenty-four premenopausal women received four weekly breast MRI. A blood sample was collected on the same day of MRI. BD was measured using a computer-based algorithm. The generalized estimation equation method was applied to model mean fibroglandular tissue volume (FV) and mean percent density (PD) from predictor variables including estradiol, progesterone, and week during a cycle. RESULTS: In week 3, a borderline significant correlation between estradiol and PD (r = 0.43, P = 0.04), estradiol and FV (r = 0.40, P = 0.05) and between progesterone and FV (r = 0.42, P = 0.04) was noted. The FV and PD measured in weeks 4 and 1 were higher than in weeks 2 and 3, adjusted for variation in endogenous estradiol and progesterone, indicating that the hormone change could not account for the changes in density. No lag effect of endogenous hormone on the change of FV or PD was noted (all P-values > 0.05). CONCLUSIONS: Our results showed that BD is not strongly associated with the endogenous hormone. Their association with breast cancer risk was likely coming from different mechanisms, and they should be considered as independent risk factors.
BACKGROUND: We measured breast density (BD) on MRI and correlated with endogenous hormonal levels. PATIENTS AND METHODS: Twenty-four premenopausal women received four weekly breast MRI. A blood sample was collected on the same day of MRI. BD was measured using a computer-based algorithm. The generalized estimation equation method was applied to model mean fibroglandular tissue volume (FV) and mean percent density (PD) from predictor variables including estradiol, progesterone, and week during a cycle. RESULTS: In week 3, a borderline significant correlation between estradiol and PD (r = 0.43, P = 0.04), estradiol and FV (r = 0.40, P = 0.05) and between progesterone and FV (r = 0.42, P = 0.04) was noted. The FV and PD measured in weeks 4 and 1 were higher than in weeks 2 and 3, adjusted for variation in endogenous estradiol and progesterone, indicating that the hormone change could not account for the changes in density. No lag effect of endogenous hormone on the change of FV or PD was noted (all P-values > 0.05). CONCLUSIONS: Our results showed that BD is not strongly associated with the endogenous hormone. Their association with breast cancer risk was likely coming from different mechanisms, and they should be considered as independent risk factors.
Entities:
Keywords:
MRI; breast density; endogenous hormone; fibroglandular tissue volume; lag effect; percent density
Authors: Norman F Boyd; Lisa J Martin; Limei Sun; Helen Guo; Anna Chiarelli; Greg Hislop; Martin Yaffe; Salomon Minkin Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-11 Impact factor: 4.254
Authors: A Heather Eliassen; Stacey A Missmer; Shelley S Tworoger; Donna Spiegelman; Robert L Barbieri; Mitch Dowsett; Susan E Hankinson Journal: J Natl Cancer Inst Date: 2006-10-04 Impact factor: 13.506
Authors: Jean-Paul Delille; Priscilla J Slanetz; Eren D Yeh; Daniel B Kopans; Leoncio Garrido Journal: Breast J Date: 2005 Jul-Aug Impact factor: 2.431
Authors: E White; P Velentgas; M T Mandelson; C D Lehman; J G Elmore; P Porter; Y Yasui; S H Taplin Journal: J Natl Cancer Inst Date: 1998-06-17 Impact factor: 13.506
Authors: Anna H Wu; Darcy Spicer; Agustin Garcia; Chiu-Chen Tseng; Linda Hovanessian-Larsen; Pulin Sheth; Sue Ellen Martin; Debra Hawes; Christy Russell; Heather MacDonald; Debu Tripathy; Min-Ying Su; Giske Ursin; Malcolm C Pike Journal: Cancer Prev Res (Phila) Date: 2015-08-14
Authors: Seungyoun Jung; Frank Z Stanczyk; Brian L Egleston; Linda G Snetselaar; Victor J Stevens; John A Shepherd; Linda Van Horn; Erin S LeBlanc; Kenneth Paris; Catherine Klifa; Joanne F Dorgan Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-11-04 Impact factor: 4.254
Authors: Seungyoun Jung; Brian L Egleston; D Walt Chandler; Linda Van Horn; Nola M Hylton; Catherine C Klifa; Norman L Lasser; Erin S LeBlanc; Kenneth Paris; John A Shepherd; Linda G Snetselaar; Frank Z Stanczyk; Victor J Stevens; Joanne F Dorgan Journal: Breast Cancer Res Date: 2015-06-04 Impact factor: 6.466
Authors: Lauren C Houghton; Seungyoun Jung; Rebecca Troisi; Erin S LeBlanc; Linda G Snetselaar; Nola M Hylton; Catherine Klifa; Linda Van Horn; Kenneth Paris; John A Shepherd; Robert N Hoover; Joanne F Dorgan Journal: Breast Cancer Res Date: 2019-11-14 Impact factor: 6.466
Authors: Martina Dzoic Dominkovic; Gordana Ivanac; Kristina Bojanic; Kristina Kralik; Martina Smolic; Eugen Divjak; Robert Smolic; Boris Brkljacic Journal: Diagnostics (Basel) Date: 2020-06-10